The Annals the journal of Pharmacy Technology
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

The Annals of Pharmacotherapy: Vol. 29, No. 3, pp. 314-315.
© 1995 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baldinger, S.
Right arrow Articles by Schroeder, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baldinger, S.
Right arrow Articles by Schroeder, D.

Research Articles

Nicotine therapy in patients with Alzheimer's disease

SL Baldinger and DJ Schroeder

Further studies are needed to determine the long-term effects nicotine may have in patients with Alzheimer's disease. In addition, one must consider the risks of using a chemical that is considered a health hazard to treat a patient with Alzheimer's disease. It would be beneficial to develop a compound similar to but less toxic than nicotine to study and possibly treat patients with Alzheimer's disease. Until alternatives are developed, a trial of nicotine administered transdermally may provide hope and a greater understanding of Alzheimer's disease.




homecopy help contact us subscription past issues search current issue
Copyright © 1995 by Harvey Whitney Books Company.